Laser and Skin Surgery Center of New York Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00747903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Laser and Skin Surgery Center of New York | Roy G. Geronemus, M.D.

Active Ingredients

Drugs in Phase 4 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 2 Trials (2)

aminolevulinic acid (levulan) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cicatrix, Hypertrophic (Phase 2)

Hypertrophy (Phase 2)

Melanosis (Phase 4)

Skin Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3